Pioneering microbiome science for

human and planetary health

Dr. Alessio Fasano

Seed Health Scientific Board

We are at the dawn of a new scientific revolution. Our understanding of how to treat and prevent diseases has been transformed by knowledge of the microbiome—the rich ecosystem of microorganisms in and on every human. These microbial hitchhikers may hold the keys to human health.

A Bio Revolution

An ecology of 38 trillion microbes lives within each of us.

This is our microbiome—it expresses 100x more genes than our human cells and co-evolved with us over 2 million years1. Unlike our genome, the microbiome is dynamic, ever-responding to our environment and choices—revealing a novel pathway for well-being that radically evolves how we live and our paradigms of care.

As the modern world impacts human health and that of all living organisms, the microbiome moves us beyond prevention and treatment to a sustainable, systems-based future.

End-to-End Platform
—From Discovery through Impact

Early attempts to realize the potential of the microbiome have been limited by primitive tools, small data sets, and shallow sequencing. Utilizing advanced computational biology, microbial genomics, and ultra-deep sequencing, we construct proprietary data clouds to elucidate host-microbe interactions and provide unparalleled insight into the microbiome’s role in human health.

This insight, paired with our powerful commercialization engine, fuels our end-to-end platform to advance breakthrough research from discovery to real-world impact.

Human-First Discovery

Our platform is fueled by large, multi-omics, controlled data sets and human-centric testing models.

Programs

Our research programs drive product innovation in multiple categories to optimize the development and maturation of the human microbiome from birth through healthy aging.

The first three years of life are a critical developmental window for humans, encompassing microbiome seeding, immune system maturation, and metabolic priming. Our suite of microbiome-centric solutions seeds the appropriate bacteria at the optimal time to establish a strong symbiotic host-microbiome relationship from the beginning of life.

Key Scientists

Eran Segal Ph.D, The Weizmann Institute of Science
Cezmi Akdis, MD, University of Zurich (SIAF)
Jacques Ravel, PhD, University of Maryland School of Medicine

Applications

Gastrointestinal Health 
Dermatological Health

2018 SEED 2682 3

Pipeline

Our translational work culminates in the discovery and validation of novel applications of prebiotics, probiotics, postbiotics, and synbiotics for key windows of intervention throughout life.

View
Program

Gut Health–Brain Health | Infant

Consumer Application:GBH-01 • Prebiotic

status: Development

Gut Health–Skin Health | Infant

Consumer Application:GSH-01 • Prebiotic + Probiotic + Postbiotic

status: Discovery

Skin Health | Infant

Consumer Application:SH-01 • Prebiotic

status: Discovery

Gut Health | Pediatric

Consumer Application:PDS-08® • Synbiotic for intermittent constipation, immune, & respiratory health

status: GTM

Gut Health–Brain Health | Pediatric

Consumer Application:GBH-01 • Prebiotic

status: Development

Skin Health | Pediatric

Consumer Application:SH-01 • Prebiotic

status: Discovery

Nutrition | Pediatric

Consumer Application:PN-01 • Prebiotic

status: Discovery

Gut Health | Adult

Consumer Application:DS-01® • Synbiotic delivering broad-spectrum probiotic species for whole-body health

status: GTM

Gut Health–Brain Health | Adult

Consumer Application:GBH-01 • Prebiotic

status: Development

Skin Health | Adult

Consumer Application:SH-01 • Prebiotic

status: Discovery

Consumer Application:SH-02 • Prebiotic + Postbiotic

status: Discovery

Vaginal Health | Adult

Consumer Application:VH-01 • Synbiotic

status: Clinical

Consumer Application:VH-02 • Abiotic

status: Discovery

Therapeutic Application:VHT-01 • Live biotherapeutic for cervical cancer prevention

status: Development

Therapeutic Application:VHT-02 • Live biotherapeutic for recurrent UTI

status: Development

Metabolic Health | Adult

Consumer Application:MH-01 • Synbiotic

status: Discovery

Nutrition | Adult

Consumer Application:PN-01 • Prebiotic

status: Discovery

Gut Health | Aging

Consumer Application:GH-02 • Synbiotic

status: Discovery

Metabolic Health | Aging

Consumer Application:MH-01 • Synbiotic

status: Discovery

Environmental Health

Born from our belief that health is not just human, we founded SeedLabs to advance emergent research and microbial innovations to address some of the greatest environmental challenges induced by human activity.

George Church (Ph.D)

Seed Health Scientific Board

As we delve deeper into the untapped world of microbial life, we uncover transformative solutions that can significantly improve planetary health and pave the way for a more sustainable future.

Us

Pioneers in the translation of microbiome science for human and environmental health.

Learn More

One billionth the size the point of a pen
microscopic but on a macro level within
And unfurled the swirling cloud of light
A star city, a galaxy, with all its might.

GZA, The Spark